期刊文献+

四川省两县(区)乙型肝炎病毒S基因和P基因变异分析 被引量:1

Analysis on Mutation of S gene and P gene of Hepatitis B Virus in Two Counties of Sichuan Province
原文传递
导出
摘要 目的分析四川省两县(区)乙型肝炎(乙肝)病毒(Hepatitis B Virus,HBV)S基因和P基因变异。方法从乙肝病毒表面抗原、乙肝病毒e抗原均阳性的血清中提取病毒脱氧核糖核酸,经聚合酶链反应和核苷酸测序后,比较和分析S基因和P基因核苷酸和氨基酸变异。结果47例慢性HBV感染者血清标本中,12份标本在"a"决定簇内出现氨基酸变异(25.53%),分别为T126A、I126T/S、P127T、T131N、M133L、M133T、T140I;变异主要集中在"a"决定簇的第1环上(92.86%,13/14)。1份标本逆转录酶C域中出现rtV207I变异。结论自然发生的氨基酸变异主要集中在"a"决定簇的第1环上,其抗原性已改变,对乙肝疫苗接种人群构成了潜在的威胁。拉米夫定耐药株也可在未接受核苷(酸)类药物治疗的病人中发现。 Objective To analyze HBV S gene/P gene mutation in 2 counties(districts)of Sichuan province. Methods HBV DNA were extracted from sera positive both for HBsAg and HBeAg. After PCR and nucleotide sequencing, nucleotide/amino acid mutation in S and P gene were compared and analyzed. Results Of 47 serum samples from patients with chronic HBV infection,amino acid mutation in ‘a’ determinant occurred in 12 samples(25.53%, 12/47),correla- ting with T126A, I126T/S, P127T, T131N, M133L, M133T and T140I; high proportion of mutation clustered in first loop of ‘a’ determinant(92.86% ,13/14),rtV207I mutation in C domain of reverse transcription occured in one sample. Conclusion Naturally occurring mutation in ‘a ’ determinant clustered predominantly in the first loop and usually associated with altered antigenicity,posing a potential threat to successfully vaccinated individuals; Lamivudine-resistant mutant might occur in patient even without nucleotide analogue treatment.
出处 《中国疫苗和免疫》 CAS 2009年第1期45-48,共4页 Chinese Journal of Vaccines and Immunization
关键词 乙型肝炎病毒 S基因 P基因 变异 Hepatitis B virus S gene P gene Mutation
  • 相关文献

参考文献3

二级参考文献24

  • 1侯金林,骆抗先,梁炽森,王战会.HBsAg阴性乙型肝炎病毒感染与S基因插入变异的关系[J].中华传染病杂志,1996,14(3):129-133. 被引量:41
  • 2Tonekaboni SS, Waters JA, Jeffers S, et al. J Med Virol, 2000; 60 (2): 113
  • 3Mangold CMT, Unckell P, Werr M,et al. Virology, 1995;211(2):535
  • 4Matsumoto T, Nakata K, Hamasaki K, et al. J Med Virol, 1997; 53 (3): 225
  • 5Roznovsky L, Harrison TJ, Fang ZL, et al. J Med Virol, 2000 ; 61(1) :11
  • 6Wu L, He JW, Yao X, et al. J Med Virol,1999;59(4) :424
  • 7Coleman PF, Chen YCJ and Mushawar IK. J Med Virol,1999;59(1):19
  • 8Oketani M, Oketani K, Xiaohong C, et al. J Med Virol, 1999; 58 (4): 332
  • 9Saito T, Shinzawa H, Uchida T, et al. J Med Virol, 1999; 58 (4): 325
  • 10Kato J, Hasegawa K, Torii N, et al. Hepatology, 1996;23(3):389

共引文献41

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部